The present study suggests that cucurbitacin D may exert its anti-cancer effect in CRC by targeting multiple pathways including ‘PI3K-Akt signaling pathway’, ‘JAK-STAT signaling pathway’, ‘ErbB signaling pathway’ and so on. The gene discussed is EGFR; the disease is colorectal carcinoma.